As mentioned above, insulin-producing cells generated either by transdifferentiation of MSCs or by delivery of insulin gene into MSCs are able to act as replacement β-cells for the transplantation therapy of type 1 diabetes. This evidence concerns the gene INS and type 1 diabetes mellitus.